Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4604333
Author(s) Bhadhuri, Arjun; Kind, Paul; Salari, Paola; Jungo, Katharina Tabea; Boland, Benoît; Byrne, Stephen; Hossmann, Stefanie; Dalleur, Olivia; Knol, Wilma; Moutzouri, Elisavet; O'Mahony, Denis; Murphy, Kevin D.; Wisselink, Linda; Rodondi, Nicolas; Schwenkglenks, Matthias
Author(s) at UniBasel Salari, Paola
Bhadhuri, Arjun
Schwenkglenks, Matthias
Year 2020
Title Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy
Journal Health and quality of life outcomes
Volume 18
Number 1
Pages / Article-Number 317
Mesh terms Activities of Daily Living, psychology; Aged; Aged, 80 and over; Female; Humans; Male; Multimorbidity; Polypharmacy; Psychometrics, instrumentation; Quality of Life; Reproducibility of Results; Surveys and Questionnaires, standards
Abstract Background: The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of life measures, which may be used in clinical and health economic research. They measure impairment in 5 aspects of health: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The aim of this study was to assess the performance of the EQ-5D-3L and EQ-5D-5L in measuring the self-reported health status of older patients with substantial multimorbidity and associated polypharmacy.Methods:Between 2017 and 2019, we administered EQ-5D-3L and EQ-5D-5L to a subset of patients participating in the OPERAM trial at 6 months and 12 months after enrolment. The OPERAM trial is a two-arm multinational cluster randomised controlled trial of structured medication review assisted by a software-based decision support system versus usual pharmaceutical care, for older people (aged ≥70 years) with multimorbidity and polypharmacy. In the psychometric analyses, we only included participants who completed the measures in full at 6 and 12 months. We assessed whether responses to the measures were consistent by assessing the proportion of EQ-5D-5L responses, which were 2 or more levels away from that person’s EQ-5D-3L response. We also compared the measures in terms of informativity, and discriminant validity and responsiveness relative to the Barthel Index, which measures independ-ence in activities of daily living.Results:224 patients (mean age of 77 years; 56% male) were included in the psychometric analyses. Ceiling effects reported with the EQ-5D-5L (22%) were lower than with the EQ-5D-3L (29%). For the mobility item, the EQ-5D-5L demonstrated better informativity (Shannon’s evenness index score of 0.86) than the EQ-5D-3L (Shannon’s evenness index score of 0.69). Both the 3L and 5L versions of EQ-5D demonstrated good performance in terms of discriminant validity, i.e. (out of all items of the EQ-5D-3L and EQ-5D-5L, the pain/discomfort and anxiety/depression items had the weakest correlation with the Barthel Index. Both the 3L and 5L versions of EQ-5D demonstrated good responsiveness to changes in the Barthel Index.
Publisher BMC
ISSN/ISBN 1477-7525
URL https://hqlo.biomedcentral.com/articles/10.1186/s12955-020-01564-0
edoc-URL https://edoc.unibas.ch/78739/
Full Text on edoc Available
Digital Object Identifier DOI 10.1186/s12955-020-01564-0
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/32993637
ISI-Number WOS:000576933900001
Document type (ISI) Journal Article, Randomized Controlled Trial
 
   

MCSS v5.8 PRO. 0.390 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
10/05/2024